One Sentence Summary: Single cell chromatin accessibility reveals a high-resolution, continuous landscape of regulatory variation in human hematopoiesis.
Introduction
In 1957, Conrad Waddington developed a fertile analogy for developmental cell biology by conceptualizing cellular differentiation as a ball rolling down a bifurcating three-dimensional surface 1, 2 . This epigenomic landscape defines a descriptive pathway that a cell might follow, choosing different developmental fates as it reaches saddle points that separate different, increasingly restricted, cellular states. The shape of this epigenomic landscape is largely defined by transcription factors, which recruit chromatin effectors to reconfigure chromatin 3, 4 and promote new cellular phenotypes 5, 6 . These master TF regulators represent "guy-wires" that pull on this landscape, creating troughs sufficient to attract cells into specific developmental trajectories.
These concepts -the first a descriptive notion of development (Extended Data Fig. 1a) , and the second a mechanistic description of the molecular actors that drive state changes (Extended Data Fig. 1b ) -have animated a conceptual framework for understanding cell fate choices for almost 60 years. Recent technological advances in single-cell epigenomic assays [7] [8] [9] [10] [11] [12] now provide the opportunity to imbue this allegorical landscape with molecular details by measuring both the overall shape of this epigenomic landscape, as well as the activity of master regulators, or "guy wires", that influence cell fate decisions, within individual cells during normal tissue differentiation.
Hematopoietic differentiation serves as an ideal model for exploring the nature of multipotent cell fate decisions 13 . The hematopoietic system is maintained by the activity of a small number of self-renewing, long-lived hematopoietic stem cells (HSCs) capable of giving rise to the majority of blood cell lineages 13, 14 whereby multipotent cells transit multiple decision points while becoming increasingly lineage-restricted (Fig. 1a) . The human hematopoietic system is an extensively characterized adult stem cell hierarchy with diverse cell types capable of phenotypic isolation with multi-parameter fluorescence activated cell sorting (FACS) 15 . This capacity for phenotypic isolation has enabled measurement of the epigenomic and transcriptional dynamics associated with sorted progenitors across human 16, 17 and mouse [18] [19] [20] differentiation, providing a foundation for the dissection of regulatory variation in normal multi-lineage cellular differentiation.
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To define the single-cell epigenomic landscape of this developmental hierarchy, we used a single cell assay of transposase accessible chromatin by sequencing (scATAC-seq) 7 to generate data from 10 sortable populations in human bone marrow or blood comprising multipotent and lineage restricted progenitors, which includes HSCs. We find that the regulatory landscape of human hematopoiesis is continuous, with cell surface markers reflecting epigenomic "basins" across this landscape. However, our single-cell analyses also uncovered substantial epigenomic heterogeneity within immunophenotypically-defined cellular populations, including epigenomic variability within multipotent progenitors strongly correlated along the dimensions of hematopoietic differentiation -evidence for regulatory lineage priming across multipotent progenitors. We also observe epigenomic variability within immunophenotypically-defined populations of common myeloid progenitor (CMP) and granulocyte-macrophage progenitor (GMP) cell types. Using RNA-seq, we confirm that GMPs are substantially heterogeneous on both epigenomic and transcriptomic levels, and describe a new strategy to enrich for subpopulations within GMPs at different developmental stages of a continuous myeloid differentiation trajectory. Last, we identify diverse regulatory dynamics at individual cis-regulatory elements, governed by relatively few overall trans-factor accessibility programs that shape the myeloid developmental trajectory. Thus, single-cell epigenomic analysis offers a platform for de novo discovery of cell types and states, defines regulatory variability within immunophenotypically pure populations, and captures the regulatory dynamics across a cell-resolved epigenomic landscape of differentiation first conceptualized by Waddington.
Results

Single-cell epigenomics of distinct hematopoietic cell types
We used FACS to isolate 8 distinct cellular populations from CD34 + human bone marrow, which included cell types spanning the myeloid, erythroid, and lymphoid lineages (Fig. 1a,b) . In addition, we also profiled a CD34+CD38-CD45RA + CD123 -subset which has previously not been extensively functionally characterized 21 . We found that sorted cells (fresh) and cells cryopreserved after sorting (frozen) were highly comparable in their scATAC-seq data quality and yield (Extended Data Fig. 1c-e ) and therefore performed all further scATAC-seq measurements on cells cryopreserved after FACS sorting (Fig. 1c) . Together, this sorting strategy captures ~97% of all CD34 + cells (Extended Data Fig. 1f ) and using post-sort analysis, we found that sorted cell types were on average 97% pure by cell surface marker immunophenotype 17 . Using this approach, we profiled the chromatin accessibility landscapes (referred to here as epigenomes for simplicity) across a total of 30 independent single-cell experiments representing 6 human donors, with each population assayed from two or more distinct donors. The data collected from each cell type roughly approximates the observed cell type frequencies from in vivo hematopoiesis (Extended Data Fig. 1g ).
Aggregated single-cell profiles closely resemble bulk CD34 + ATAC-seq profiles (Fig. 1d,   Extended Data Fig. 1h,i) . Including previously published scATAC-seq data from LMPPs and monocytes 17 , this raw data set comprised 3,072 single-cell epigenomes across 32 integrated fluidic circuits (IFCs). Single-cell profiles were of consistent high-quality with 2,231 cells passing stringent quality filtering, yielding a median of 9,547 filtered fragments per cell with 76% of those fragments in peaks ( Fig. 1e; see methods) .
Transcription factor activity inference using ChromVAR
We adapted our previous approach for finding cell-to-cell differences using transcription factor motifs to identify potential regulators of epigenomic variability 7 . In brief, this approach quantifies accessibility variation across single cells by aggregating fragments across accessible regions containing a specific transcription factor motif, then compares this aggregate accessibility to aggregate accessibility found in a set of background accessible regions matched for known technical confounders (GC content and overall accessibility). The method, we refer to as
ChromVAR, provides a non-parametric measure of chromatin accessibility variation associated with transcription factor motifs, herein referred to as TF z-scores (Schep et al.) . Using this approach we identify high-variance TF motifs representing known master regulators of hematopoiesis such as GATA1, BATF and CEBPB (Fig. 1f) . In addition, hierarchical clustering of the TF z-scores generally classifies single cell profiles by their immunophenotypically-defined cell type identity (Extended Data Fig. 2a ).
Mapping single epigenomes on hematopoietic principal components
To map each single-cell to trajectories of hematopoietic development, we reasoned that co-variance of regulatory activity in bulk hematopoietic samples 22 would provide a natural subspace for dimensionality reduction of our single-cell data. Therefore, we implemented a computational strategy that first identifies principal components (PCs) of variation in bulk ATACseq samples (Extended Data Fig. 3a) , then scores each single-cell by the contribution of each PC. Cells are subsequently clustered using the Pearson correlation coefficients between these normalized PCs scores and all other cells (Extended Data Fig. 3b ). For low-dimensional visual representation, we performed PCA on this correlation matrix (Fig. 2a,b) , and display the first 3 principal components, which represent 93.7% of the variance (Extended Data Fig. 3c ).
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We validated this computational approach by down sampling bulk epigenomes across different patients to the approximate number of fragments per single-cell profile (Extended Data Figure 3d ). We find that clustering samples down sampled to 10 4 fragments using this PCAprojection approach closely follows sample clustering using the full data set 17 . We next downsampled ensemble single-cell profiles to match the depths observed in single-cell experiments and quantified the expected mean error to be 1.95, 1.70 and 3.1% of the total signal for PCs 1-3 respectively (Extended Data Fig. 3e,f) . To test our sensitivity for identifying intermediate cell states, we created synthetic mixtures from ensemble profiles, down-sampled to 10 4 fragments and found these synthetic mixtures to closely follow the expected paths (Extended Data Fig.   3i ,j). Thus this projection provides a descriptive landscape of human hematopoietic differentiation akin to Waddington's conception (Extended Data Fig. 1a,b) , while the layering of TF z-scores onto this representation provides insight into the "guy wires" that may underlie epigenomic changes during the differentiation process.
Waddington landscape of human hematopoiesis: A manta ray
Projecting our scATAC-seq data using this method, the epigenomic landscape of human hematopoiesis resembles a swooping manta ray, with hematopoietic cell types generally localizing together (Fig. 2a) . HSC (head, in dark green), LMPP and MPP (right and left shoulders, in teal and light green respectively), followed by broad groups of CMP and GMP cells (tan and light brown, respectively) that comprise the "body" of the figurative manta ray. Differentiation into CLP and pDC (right fins, blue and purple), MEP (left fin, red), and monocytes (tail, orange) appear as differentiation trajectories that swoop away from the body (Fig. 2b) . Furthermore, motifs associated with master lineage regulators ID3, CEBPB and GATA1 13 show continuous gradients of activity across lymphoid, myeloid, and erythroid development, while the HSC and LMPP compartment show higher accessibility associated with HOX motifs, previously shown to regulate stem cell activity 23, 24 ( Fig. 2c-f) . We also observe possible examples of cell type contamination from FACS misclassification, particularly between CMP:MPP, GMP:LMPP (separated by CD38) and GMP:CLP (separated by CD10) likely due to the continuous nature of the markers used to separate these subpopulations (Extended Data Fig. 4 ).
We found that CMP, GMP and MEP profiles appear markedly heterogeneous in this composite epigenomic space. We quantified the heterogeneity across each population by comparing the observed epigenomic variability in this space to down-sampled aggregate profiles and found CMPs to be the most heterogeneous cell type (p < 10 -111
), however, all cell types displayed statistically significant heterogeneity (Extended Data Fig. 5a ). To further validate this ubiquitous epigenomic heterogeneity, we compared our results to results obtained after permuting peaks matched in mean accessibility and GC content (see methods) and find that the observed heterogeneity remains statistically significant with the exception of monocytes (p = 0.35; Fig. 5b,c) . Finally, single-cell TF z-scores (Schep et al.) , which are calculated in an unrelated manner to this PCA projection, also exhibit significant variability (Extended Data   Fig. 5d ). Thus rather than identifying a series of discrete cellular states (Fig. 1a) , these results suggest that the epigenomic landscape in early hematopoietic differentiation (HSC, MPP, LMPP and CMP) comprises a fairly broad basin of cellular states, while paths of later differentiation are more significantly canalized into distinct, however also continuous, myeloid, erythroid and lymphoid cell differentiation trajectories. We encourage the reader to explore the single cell epigenomic landscape using our interactive 3D viewer scHemeR (http://schemer.buenrostrolab.com/).
Extended Data
De novo identification of uncharacterized epigenomic states
Given the observed limitations of our sort markers, we sought to define hematopoietic cell types de novo by applying k-medoids clustering on this principal component projection. We (Fig. 3c) . We find that CMPs are separable into 4 distinct clusters, represented here as clusters 2-5. In addition, we also find that MEP, GMP and pDCs comprise two distinct clusters each, possibly representing early-and late-stage progenitor differentiation.
We sought to further define these clusters by using transcription factor motif accessibility 7 .
We visualized the activity patterns of TF motifs using t-SNE of the single-cell TF Z-scores ( Fig.   3d ) and hierarchical clustering of the mean scores across the 14 clusters (Fig. 3e) . This analysis identified key hematopoietic regulators de novo, including motif associated with well-described master regulators such as GATA1 (erythroid), CEBPD (myeloid) and EBF1 (lymphoid) lineagespecifying factors 13 . Notably, we also find a specific HSC cluster of TFs that include HOX, ERG and MAFF motifs (see supplementary materials for a complete list of TF z-scores).
Epigenomic variability within EIPP pure clusters
We next asked if we could see evidence of lineage-specific epigenomic signatures in stringently-defined progenitor subpopulations. To quantify this epigenomic variability, we created highly stringent cluster definitions that required classified cells to be both epigenomically (clusterpure) and immunophenotypically pure (we term these EIPP clusters, see methods). We then computed TF z-scores (Schep et al.) for cells within each EIPP cluster (Extended Data Fig. 6a) and found substantial epigenomic heterogeneity within these subsets. We first explored the distribution of epigenomic variability observed in HSCs and found GATA2 and MESP1 TF zscores to be significantly correlated to erythroid and lymphoid trajectories respectively ( Fig. 3f-h and Extended Data Fig. 6b-d) . Overall, we find much of the epigenomic variability within stringently defined EIPPs to be attributed to a developmental axis defined in our single cell PCA projection. However, we find CTCF, RELA and FLI1 motifs in HSCs to be significantly variable, however uncorrelated with any specific direction of differentiation, suggesting that these regulatory factors vary in a manner uncorrelated with the direction of hematopoietic development in this epigenomic landscape.
We next turned to LMPPs, a subset previously shown to demonstrate lineage priming toward dendritic (pDC), myeloid (GMP:Monocytes) and lymphoid (CLP:B-cell) fates in mice 25 .
Interestingly, we found TCF4, STAT1 and CEBPE TF z-scores to be significantly correlated with directionality toward CLP, pDC and GMP differentiation, respectively ( .
Cell state transitions defining myeloid cell differentiation
Recent findings have identified significant functional and transcriptional heterogeneity within the mouse 27, 28 and human 29 CMP progenitor cells, and suggest that CMPs can be further partitioned into myeloid and erythroid committed progenitors. In light of these new discoveries, we reasoned that our data may provide insight into the regulatory components defining myeloid/erythroid specification, previously confounded in bulk epigenomic studies due to the apparent heterogeneity within CMP cells. In concordance with these findings we find four CMP clusters, with significant variability across GATA1, BCL11A and SPI1 (PU.1), TFs implicated in myeloid/erythroid specification ( Fig. 4a) . Furthermore, we identified 1,801 differentially accessible regions within CMPs and using k-medoids clustering, identified distinct regulatory patterns across the four CMP subsets (see methods; Fig. 4b) . Importantly, the set of differential enhancers enriched in CMP clusters K3-K5 included two previously validated enhancers 30 shown to be important regulators of the master erythroid factor GATA1 (Fig. 4b) . Together with the TF zscores we assigned CMP clusters as CMP-K3 (early erythroid), CMP-K5 (late erythroid), CMP-K4
(unknown) and CMP-K2 (myeloid primed).
In addition to the heterogeneity within CMP cells, the GMP clusters K9 and K10 show significant differences in accessibility among myeloid-defining factors such as CEBP and SPI1
(PU.1) (Fig. 4c and Extended Data Fig. 7a) . In an effort to further define molecular differences within immunophenotypically defined GMPs, we sought to identify cell surface markers that may differentially enrich for K9 and K10 GMPs. We hypothesized that CD123 expression may correlate with early and late GMP differentiation for two reasons: (i) the UNK population, which is CD123 -, is enriched in the GMP K9 cluster and (ii) CD123, also known as IL3R, is a receptor for the myeloid promoting cytokine IL3. We therefore performed scATAC-seq, bulk ATAC-seq 31, 32 and bulk RNA-seq on cells from each of three distinct bins of CD123 expression (Fig. 4d) .
Projection of the three cell fractions using scATAC-seq data identified GMP-A as enriched in GMP K9, while GMP-B and GMP-C are enriched for GMP K10 (Extended Data Fig. 7b,c) . In addition, bulk ATAC-seq and RNA-seq data revealed significant epigenomic and transcriptomic differences across the GMP-A and GMP-C populations ( Fig. 4e and Extended Data Fig. 7d-f ).
The list of differentially expressed genes included important developmental regulators, including down regulation of HSPC TFs GATA2 and TAL1 and up regulation of myeloid genes SPI1 (PU.1), IRF8, TLR7 and MPEG1 in the GMP-C cell population (Fig. 4e) . Altogether, this single-cell and bulk analysis supports our data driven approach for uncovering developmental differences in human hematopoiesis and suggests that CD123 expression marks molecularly distinct early and late GMP progenitor populations.
Regulatory dynamics along myeloid cell differentiation
Spurred by this strong epigenomic signal of population-level heterogeneity along myeloid differentiation, we sought to project single-cells onto an inferred developmental trajectory.
Integrating both recently published work and our data described above, we reasoned that myeloid differentiation proceeds through: HSC (K1), the myeloid biased CMP (K2), GMP-A (K9), GMP-C (K10) and monocytes (K11) (Fig. 4f) . Notably, this myeloid trajectory also represents the shortest path from HSCs to monocytes in our projected hematopoietic landscape. We therefore assigned cells within these clusters to a continuous myeloid developmental order (see methods; We next characterized TF dynamics across myeloid development by mapping TF z-scores to cells along this continuous myeloid differentiation trajectory (Extended Data Fig. 8 ). Using this approach, we find 6 clusters of TF activity profiles that occur during myeloid development (Fig.   5a ). TF motifs associated with regulators HOXB8 and GATA1 motifs (cluster 1) are active in HSCs and are lost upon differentiation to CMPs. Interestingly, loss of GATA1 motif activity begins within the HSC compartment, while HOXB8 activity is lost at the transition of HSC to CMP differentiation further demonstrating that GATA motif accessibility may be involved in lineage priming of HSCs (Fig. 5b) . We also find two distinct modes of activation of myeloid-associated TFs; cluster 4 TFs (CEBP and SPIB) display early and gradual gain in activity beginning within CMPs, while cluster 5 TFs (STAT1, IRF8 and BCL11A) increase sharply in activity across the GMP-A to GMP-C transition, implicating CEBP motif activity as the initiating factor for myeloiderythroid specification (Fig. 5c) . In addition to the activity patterns associated with canonical myeloid-defining factors, we also identify a pulse of activity within CMPs from cluster 2 TFs We next sought to identify cis-regulatory activity dynamics underlying myeloid differentiation. To do this, we filtered for regulatory elements with high fragment counts and with significant variability across the ordered cells (see methods), identifying 3,403 cis-regulatory elements for analysis. From this list of regulatory elements we found highly heterogeneous patterns of activity characterized by their activation timing (Extended Data Fig. 9a-d) . For example, within the regulatory elements surrounding the myeloid regulator CEBPD (numbered for simplicity), the distal element CEBPD-1 was "fast-to-activate" and showed step-wise gains of activity while the distal element CEBPD-2 was "slow-to-activate" and showed a discrete pulse of activity (Fig. 5d,e) .
To visualize the complete repertoire of dynamic regulatory profiles, we used t-SNE to order elements based on their accessibility changes over this trajectory (see methods). This projection reveals multiple axes of regulatory element behaviors, ranging from fast-to slow-torepress HSC regulatory elements and fast-to slow-to-activate monocyte regulatory elements (Fig. 5f) . We also observe a collection of "transition" cis-regulatory elements that exhibit peak accessibility at intermediate stages of myeloid development, as well as "reactivation" elements that initially are lost and subsequently reactivated in later stages of myeloid differentiation (Fig.   5g,h ). Altogether this single-cell resolved regulatory analysis of myeloid cell development revealed 6 discrete clusters of TF motif activity, however, we find that these relatively simple patterns of trans-dynamics yields highly diverse cis-regulatory profiles likely arising from the large combinatorial control of trans-factors on their cognate regulatory elements (Extended Data Fig.   9e ).
Discussion
We used single-cell epigenomic analysis to identify regulatory heterogeneity and continuous differentiation trajectories in a human differentiation hierarchy. We find that immunophenotypically-defined cell populations often flow from one state to another within the instantiation of the epigenomic landscape will likely require direct estimates of transition probabilities, either through sorting marker-pure HSPC subpopulations followed by time-point analysis of differentiation or through the emerging repertoire of CRISPR-based tools for kinetic lineage tracking 35, 36 , which would unravel the dynamic nature of chromatin state changes and the potential for reversibility.
We anticipate future work will experimentally or computationally pair epigenomic and transcriptomic data to enable an integrative regulatory model of dynamic cellular processes, providing insight into the temporal function of trans regulators and cis-regulatory elements. 25, 26 , and recent work has shown mouse lineageprimed HSCs to exhibit extensive epigenomic differences (assayed using ATAC-seq) with little to no transcriptomic differences 37 . However, one might expect other biological phenomena that require fast stimulus-response programs to bypass chromatin changes, and exhibit differences in RNA or protein modifications 38 . In either case, we anticipate that single-cell epigenomics assays will provide a platform for unraveling cis-and trans-regulatory changes associated with dynamic differentiation trajectories or tissue identity in an immunophenotypically unbiased and data driven manner. 
Materials and Methods
Cell collection and isolation:
Human bone marrow was sorted as described previously 17 . In addition to the cell types previously described, we also isolated plasmacytoid dendritic cells (pDCs) and megakaryocytes. 
Single-cell ATAC-seq
Single-cells not cryopreserved after FACS (fresh) were assayed as previously described 7 .
To assay cells cryopreserved after FACS (frozen), cells were allowed to recover for 10 min at ThermoMixer with agitation at 300 rpm. The transposed DNA fragments were purified and amplified as described 17 .
For bulk RNA-seq, cells were split into 2 technical replicates. RNA was isolated using the Qiagen RNeasy Plus Micro kit, and RNA was eluted in 10 μ l of RNase-free water. 5 μ l of total RNA was used as input for NuGen Ovation V2 cDNA synthesis kit. The yield of purified SPIAamplified cDNA was measured using Qubit dsDNA HS Assay kit. 50 ng of SPIA cDNA was fragmented using Nextera DNA library preparation kit (Illumina, FC-121-1030). Fragmented SPIA cDNA was then purified using Qiagen MinElute Reaction Cleanup Kit, and purified DNA was eluted in 10 μ l of elution buffer (10mM Tris-HCl, pH 8). Purified SPIA cDNA fragments was amplified and purified as previously described for ATAC-seq 17 . ATAC-seq and RNA-seq libraries were quantified using qPCR, amplified libraries were sequenced using paired-end, dual-index sequencing on a NextSeq 500 instrument with 76 bp read lengths.
Data pre-processing and TF scores
Single-cell and bulk ATAC-seq alignment, quality filtering and peak calling was performed as previously described 17 , with one exception. For single-cell profiles, any read-pair that occurred in two cells from the same experiment (a single 96-cell IFC) was removed from further analysis.
Using the previously described approach 17 , we defined a peak list using all bulk hematopoietic data analyzed here, resulting in 491,437 500bp non-overlapping peaks which we use for the reminder of this study. To count the number of fragments per peak in a sample or cell, and also for computing TF z-scores per cell, we used the default settings in the chromVAR package (Schep et al.) . Bulk counts were normalized as described previously 17 using quantile normalization and the CQN package.
PCA projection and clustering cells
To calculate PCs on the bulk data sets, used or projecting single-cell profiles, we first removed peaks in annotated promoters or aligning to chrX, peaks associated with chrY and unmapped contigs were filtered out in the preprocessing steps. 455,057 peaks remained after filtering and were used for the PCA projection analysis. To score single-cells by the activity for each component, we first centered the counts for each cell by dividing each peak by the mean fragment counts in peaks for a given cell. We then used the weighted coefficients for each peak and PC (determined using PCA-SVD of the bulk data above) to take the product of the weighted PC coefficients by the centered count values for each cell, taking the sum of this value resulted in a matrix of cells by PCs. Last, we calculate a cell-cell similarity matrix using Pearson correlation and perform PCA on the similarity matrix of correlation values. To validate the computational approach we repeated this procedure for the bulk data, down sampled bulk data, mean single-cell profiles and synthetic mixtures. Notably, we found a patient-specific batch effect in the HSC single-cell profiles in the PCA projected subspace. The batch signal was strongly correlated with Jun/Fos TF z-scores. We therefore normalized each HSC batch to the mean values of all HSC profiles, and in addition, blacklisted all motifs correlated with Jun/Fos activity. We use these corrected PC values and filtered TF motifs for all subsequent visualizations of these data.
To determine significant cell-cell variability in the PC projected sub-space, we either down sampled or permuted peaks by their GC content and mean accessibility. To permute peaks that match GC% and mean accessibility, we take the sum accessibility of all cells of a given immunophenotypically defined cell type (e.g. HSCs) and use the ChromVAR function "get_background_peaks" with the default settings. Notably, ChromVAR samples background peaks with replacement and may select the observed peak as a background peak, and therefore provides a conservative estimation of excess variability.
Hierarchical clustering, K-medoids and computing density
All hierarchical clustering performed used Pearson correlation as the distance function. All k-medoids clustering shown in this work is performed using 10 replicates with the distance function Pearson correlation. The gap statistic is used to determine the appropriate number of clusters, here the optimal cluster number is determined wherein the minimum K satisfies the follow criteria: the gap value for a given K is greater than the gap value of K+1 minus the standard error of the clustering solution for K+1. The first 5 PCs were chosen for clustering cells by their projected PC values. All metrics of data density shown in this work are weighted by the expected in vivo frequency of each cell type, as measured from flow cytometry data. 3D data density is calculated as the mean number of cells within a radius of 1, weighted by the in vivo frequency. 2D data density is calculated using KDE weighted by the in vivo frequency.
Lineage bias analysis
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To compute TF variability within epigenome and immunophenotype pure (EIPP) cells, we first determined the dominant cell type for each of the 14 k-medoids determined clusters. We then collected 14 cluster-pure and immunophenotype-pure profiles and proceeded to compute variability and TF z-scores using ChromVAR (Schep et al.) . To determine the magnitude and direction of the TF lineage bias, we first partitioned TF z-scores as greater than zero (high) or less than zero (low). We then computed the mean of the first 5 PCs from the PCA projection for the cells assigned to the high or low TF z-score, distance of the high and low centroids was calculated using Euclidean distance. We determined significance using "direction z-scores", whereby we repeated the analysis described above for PCs calculated using 50 background peak permutations matching GC and mean accessibility, peaks were determined using ChromVAR (Schep et al.) . Direction z-scores were computed comparing the observed to the 50 permuted distances.
Identifying significantly differential CMP peaks
To determine differential CMP peaks, aggregate CMP profiles for each k-medoids cluster were collected. Pairwise binomial tests were performed for each aggregate profile (4 CMP clusters) for each peak. Peaks with a p-value of <10 -5 in one or more comparisons was used for further analysis (n = 1,801 peaks). For clustering and visualization, counts were normalized using column z-scores and clustered using k-medoids, the gap statistic (as described above) was used to determine a K of 6.
Ordering cells in myeloid pseudo-time and determining smoothed scores
To order cells by myeloid development, only cells within clusters K1, K2, K9, K10, K11
were considered. To determine a continuous trajectory we first fit a line through each cluster centroid using a linear interpolation across the 5 PCs. To assign each cell to the linear trajectory, we determined the closest point of each cell to the interpolated fit line. To determine the regulatory activity dynamics across this inferred trajectory, we smoothed the TF z-scores along myeloid progression with a lowess function with a span of 200, implemented within the MATLAB function smooth. Continuous profiles were normalized by their min/max value for plotting and downstream clustering. To determine 95% confidence intervals we sampled cells (n=100 permutations) with replacement and repeated the smoothing for each permutation. Accessible peaks were similarly smoothed using a span of 500.
Filtering for variable TFs, regulatory elements and determining motif enrichment
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To determine TFs that were significantly variable within the smoothed myeloid trajectories, we compared the standard deviation of the observed smoothed scores by a set of similarly smoothed, permuted, TF scores by randomly permuting the myeloid cell order. Selecting TFs with a standard deviation greater than 0.5 provided 205 motifs with an FDR < 1%. To determine highly variable regulatory elements we first filtered for regulatory elements with greater than a mean accessibility of 0.01 fragments per cell and subsequently filtered for regulatory elements with a coefficient of variation of greater than 0.5 (n = 3,403).
To determine motif enrichment across dynamic accessible peaks, we first collected log-PWM scores per peak using ChromVAR(Schep et al.) for motifs that were selected in the TF analysis described above. Peak-to-peak distances were computed using Euclidean distance of the PC scores determined by PCA of the min/max normalized accessibility dynamics across the myeloid trajectory. For each peak, the mean log-PWM score was computed for the nearest 300
peaks.
